Created 6 AI-Based MedTech Ventures To Tackle Challenges in Mental Health

Background

Eastern Academic Health Science Network (EAHSN), is one of 15 AHSN in the UK set up to spread innovation at pace and scale across the healthcare system. They work across the East of England region to help promote health service improvement and innovation. Amongst improving the health of the local population, they aim to generate economic growth by supporting innovators. They enable companies to grow and create jobs by helping NHS organisations and industry to engage more productively, and were looking for early stage ventures to be introduced into the healthcare innovation pipeline. 

The Cambridge Judge Business School – the business school of the University of Cambridge, and Taylor Vinters, an international law firm supporting businesses which drive the innovation economy, joined the initiative as sponsors

Brief

EAHSN asked Studio Zao to create early stage ventures to be added to the innovation pipeline of the NHS healthcare system.  With the help of local health organisations such as Cambridgeshire and Peterborough NHS Foundation Trust, we agreed on the focus challenges.

• Mental Health – how might AI be applied to improve patients’ safety and prevent suicidal behaviour or detect impending violent behaviours?
• Healthy Ageing – how might AI facilitate targeted, personalised care in older people with multiple co-morbidities and to detect Alzheimer’s disease before symptoms arise?

Approach

Studio Zao collaborated with EAHSN, The Bradfield Centre and Central Working to design and run MedTechBOOST, an intensive one-week venture sprint to develop AI solutions to Mental Health and Healthy Ageing.

We managed the end-to-end programme by recruiting and teaming applicants, selecting speakers, judges and industry leading mentors, preparing and delivering the actual venture sprint content through expert facilitators and trainers on the field.

During the first two months we interviewed and screened over 60 applicants and created 6 teams all of which included industry experts and top Cambridge talent — such as researchers, PhD, post-doctorates and early-stage startups from a variety of disciplines, freelance software developers & technologists, doctors and other clinicians — for an intensive and focused 5-day venture sprint.

Day 1: teams started their entrepreneurial journey and went through lean principles. The focus was on customer segments and their problems, on ideation and on exploring revenue streams. Teams ended with a clear idea of the assumptions to be validated during day 2.

Day 2: teams were able to validate their assumptions and received senior expert guidance and mentoring from an array of programme partners including sponsors Cambridge Judge Business School Entrepreneurship Centre, as well as 18 industry partners such as AstraZeneca, Johnson & Johnson Innovation, Cambridgeshire and Peterborough NHS Foundation Trust (CPFT), Guy’s and St Thomas’​ NHS Foundation Trust, NVIDIA AI, Cambridge University Health Partners, ARM, Wellcome Genome Campus, City AI. 

Day 3: teams had the chance to build their digital prototypes with input from leading experts in UX and AI.

Day 4: teams spent the day business planning for delivering their ideas across the entire National Healthcare Service, defining next steps and their asks, and putting together their pitches.

Day 5: teams were able to refine their business propositions and rehearse their pitches. The programme concluded with a showcase where they pitched in front of 100+ public audience and discussed potential investment and collaboration with programme partners and sponsors.

Outcomes

By the end of the one-week venture sprint, 6 teams pitched their new ventures that could collectively save the NHS billions of pounds a year to a judging panel. The programme sponsor is now actively assisting them through their next steps.

Moreover, participants were able to fully understand the entrepreneurial process that covers problem definition, ideation, business modelling, rapid prototyping, assumption validation and pitching.

The judging panel included the following:

• Louise Jopling – Commercial Director, EAHSN
• Bruno Cotta – Executive Director, Cambridge Judge Entrepreneurship Centre
• Patrick Farrant – Partner, Taylor Vinters
• Lilian Alcaraz – Senior Director, New Ventures & Transactions, Neuroscience, J&J
• Anne Blackwood – CEO, Health Enterprise East
• Peter Ferguson – Director Healthcare Technologies, ARM
• Claus Bendtsen – Executive Director, AstraZeneca
• Michael Anstey – Partner, Cambridge Innovation Capital

The winning teams were:

• Best Impact in Mental Health: Equilibrium (helping bipolar patients predict mood changes – using machine learning based software which passively collects sleep and activity data to predict mood changes. The software alerts the user and directs them to support)
• Best Impact in Healthy Ageing: Cambridge MemTech (solving diagnosis of Alzheimer’s disease – by using machine learning on a global dataset to aid in decision making for clinicians and early detection).
• Best Presentation: Cam AI (reducing adolescent self-harm – using AI in social media to detect self harm imagery/wording and sending alerts to the user and signposting them to a chatbot based on CBT therapy).